LOGIN  |  REGISTER
Viking Therapeutics
Viking Therapeutics

U.S. Physical Therapy Schedules Second Quarter 2023 Earnings Release and Conference Call Dates

July 20, 2023 | Last Trade: US$87.00 2.06 -2.31

HOUSTON / Jul 20, 2023 / Business Wire / U.S. Physical Therapy, Inc. (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the three and six months ended June 30, 2023 on Tuesday, August 8, 2023, after the stock market closes, with the conference call to follow the next morning, on Wednesday, August 9, 2023.

Conference Call

 

Date:

Wednesday, August 9, 2023

  Time:

10:30 am Eastern/9:30 am Central

  Dial-In Number:

(866) 952-8559 Primary or
(785) 424-1743 Alternate

  Conference ID: USPHQ223
  

(In order to join this conference call, you will be required to provide the Conference ID listed above)

To participate, please call in 10 minutes prior to start time.

To listen to the live call, please go to www.usph.com and click on conference calls under the Investor Relations section. Please go to the website 15 minutes early to register, download and install any necessary audio software. If you are unable to listen live, a playback of the conference call can be accessed until November 7, 2023 at U.S. Physical Therapy’s website.

About U.S. Physical Therapy, Inc.

Founded in 1990, U.S. Physical Therapy, Inc. operates 656 outpatient physical therapy clinics in 40 states. The Company's clinics provide preventative and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, treatment for neurologically-related injuries and rehabilitation of injured workers. In addition to owning and operating clinics, the Company manages 43 physical therapy facilities for unaffiliated third parties, including hospitals and physician groups. The Company also has an industrial injury prevention services business which provides onsite services for clients’ employees including injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments.

More information about U.S. Physical Therapy, Inc. is available at www.usph.com The information included on that website is not incorporated into this press release.

Stock Quote

Featured Stock

Recursion

Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....

CLICK TO LEARN MORE

Featured Stock

Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page